2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

 

Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MS.

Can Routine Clinical Markers be used Longitudinally to Monitor Antiretroviral Therapy Success in Resource-Limited Settings?

Clin Infect Dis 2007;44(1):135-138.

 

Chen RY, et al.

Complete Blood Cell Count as a Surrogate CD4 Cell Marker for HIV Monitoring in Resource-Limited Settings.

J Acquir Immune Defic Syndr 2007;44(5):525-30.

 

Matthews C, Caperna J, Cachay ER, Cosman B.

Early Impact and Performance Characteristics of an Established Anal Dysplasia Screening Program : Program Evaluation Considerations

The Open AIDS Journal 2007 1 :11-20.

 

Crane, HM, Lober, W, Webster, E, Harrington, RD, Crane, PK, Davis, TE, & MM Kitahata.

Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients.

A Current HIV Research, 2007, 5(1): 109-18.

 

Dion ML, Bordi R, Zeidan J, Asaad R, Boulassel MR, Routy JP, Lederman MM, Sekaly RP, Cheynier R.

Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection.

Blood 109 (7): 2912-20, 2007

 

Luciano AA, Lederman MM, Valentin-Torres A, Bazdar DA, Sieg SF.

Impaired Induction of CD27 and CD28 Predicts Naive CD4 T Cell Proliferation Defects in HIV Disease.

J Immunol 179 (6): 3543-9, 2007.

 

Rodriguez B, Valdez H, Mijch A, Watson K, Lederman MM, McComsey GA, Loupa CV, Woolley I.

Statins Blunt HAART-Induced CD4 T-Cell Gains but Have No Long-Term Effect on Virologic Response to HAART.

J Int Assoc Physicians AIDS Care (Chic Ill), 2007.

 

Yonkers NL, Rodriguez B, Milkovich KA, Asaad R, Lederman MM, Heeger PS, Anthony DD.

TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.

J Immunol 178 (7): 4436-44, 2007.